Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA VENTILATORS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE NORTH AMERICA VENTILATORS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES VOLUME DATA
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 NORTH AMERICA VENTILATORS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 NORTH AMERICA VENTILATORS MARKET, BY TYPE
16.1 OVERVIEW
16.2 ELECTRONIC
16.3 MECHANICAL
16.4 PNEUMATIC
16.5 ELECTRO-PNEUMATIC
17 NORTH AMERICA VENTILATORS MARKET, BY PRODUCT TYPE
18 (NOTE: MARKET VALUE, VOLUME AND ASP ANALYSIS WOULD BE PROVIDED FOR ALL SEGMENTS AND SUB-SEGMENTS OF PRODUCT)
18.1 OVERVIEW
18.2 INTENSIVE CARE VENTILATORS
18.2.1 HIGH-END ICU VENTILATORS
18.2.1.1. MARKET VALUE (USD MN)
18.2.1.2. MARKET VOLUME (UNITS)
18.2.1.3. AVERAGE SELLING PRICE (USD)
18.2.2 BASIC ICU VENTILATORS
18.2.3 MID-END ICU VENTILATORS
18.3 PORTABLE VENTILATORS
18.4 NEONATAL VENTILATORS
19 NORTH AMERICA VENTILATORS MARKET, BY VENTILATION MODE
19.1 OVERVIEW
19.2 NON-INVASIVE VENTILATION
19.2.1 VOLUME-CYCLED VENTILATORS
19.2.2 PRESSURE-CYCLED VENTILATORS
19.2.3 CONTINUOUS POSITIVE AIRWAY PRESSURE VENTILATORS
19.2.4 BI-LEVEL POSITIVE AIRWAY PRESSURE VENTILATORS
19.2.5 FLOW-CYCLED VENTILATORS
19.2.6 TIME-CYCLED VENTILATORS
19.3 INVASIVE VENTILATION
20 NORTH AMERICA VENTILATORS MARKET, BY MODALITY
20.1 OVERVIEW
20.2 PORTABLE
20.3 BENCHTOP
20.4 FIXED
21 NORTH AMERICA VENTILATORS MARKET, BY AGE GROUP
21.1 OVERVIEW
21.2 ADULT VENTILATORS
21.3 NEONATAL VENTILATORS
21.4 PEDIATRIC VENTILATORS
22 NORTH AMERICA VENTILATORS MARKET, BY MODE
22.1 OVERVIEW
22.2 COMBINED-MODE VENTILATION
22.3 VOLUME-MODE VENTILATION
22.4 PRESSURE-MODE VENTILATION
22.5 OTHER
23 NORTH AMERICA VENTILATORS MARKET, BY END USER
23.1 OVERVIEW
23.2 HOSPITALS
23.2.1 PUBLIC
23.2.1.1. BY LEVEL
23.2.1.1.1. TIER 1
23.2.1.1.2. TIER 2
23.2.1.1.3. TIER 3
23.2.2 PRIVATE
23.2.2.1. BY LEVEL
23.2.2.1.1. TIER 1
23.2.2.1.2. TIER 2
23.2.2.1.3. TIER 3
23.3 AMBULATORY SURGERY CENTERS
23.4 SPECIALTY CLINICS
23.5 LONG TERM CARE CENTERS
23.6 REHABILITATION CENTERS
23.7 HOMECARE SETTINGS
23.8 OTHERS
24 NORTH AMERICA VENTILATORS MARKET, BY DISTRIBUTION CHANNEL
24.1 OVERVIEW
24.2 DIRECT TENDERS
24.3 RETAIL SALES
24.4 OTHERS
25 NORTH AMERICA VENTILATORS MARKET, BY REGION
NORTH AMERICA VENTILATORS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
25.1 NORTH AMERICA
25.1.1 U.S.
25.1.2 CANADA
25.1.3 MEXICO
25.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
26 NORTH AMERICA VENTILATORS MARKET, SWOT AND DBMR ANALYSIS
27 NORTH AMERICA VENTILATORS MARKET, COMPANY LANDSCAPE
27.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
27.2 MERGERS & ACQUISITIONS
27.3 NEW PRODUCT DEVELOPMENT & APPROVALS
27.4 EXPANSIONS
27.5 REGULATORY CHANGES
27.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
27.7 COMPANY SHARE ANALYSIS: INTENSIVE CARE VENTILATORS, NORTH AMERICA SHARE ANALYSIS
27.8 COMPANY SHARE ANALYSIS: PORTABLE VENTILATORS, NORTH AMERICA SHARE ANALYSIS
27.9 COMPANY SHARE ANALYSIS: NEONATAL VENTILATORS, NORTH AMERICA SHARE ANALYSIS
28 NORTH AMERICA VENTILATORS MARKET, COMPANY PROFILE
28.1 KONINKLIJKE PHILIPS N.V.
28.1.1 COMPANY OVERVIEW
28.1.2 REVENUE ANALYSIS
28.1.3 GEOGRAPHIC PRESENCE
28.1.4 PRODUCT PORTFOLIO
28.1.5 RECENT DEVELOPMENTS
28.2 AIR LIQUIDE
28.2.1 COMPANY OVERVIEW
28.2.2 REVENUE ANALYSIS
28.2.3 GEOGRAPHIC PRESENCE
28.2.4 PRODUCT PORTFOLIO
28.2.5 RECENT DEVELOPMENTS
28.3 HAMILTON MEDICAL
28.3.1 COMPANY OVERVIEW
28.3.2 REVENUE ANALYSIS
28.3.3 GEOGRAPHIC PRESENCE
28.3.4 PRODUCT PORTFOLIO
28.3.5 RECENT DEVELOPMENTS
28.4 MEDTRONIC
28.4.1 COMPANY OVERVIEW
28.4.2 REVENUE ANALYSIS
28.4.3 GEOGRAPHIC PRESENCE
28.4.4 PRODUCT PORTFOLIO
28.4.5 RECENT DEVELOPMENTS
28.5 GETINGE AB
28.5.1 COMPANY OVERVIEW
28.5.2 REVENUE ANALYSIS
28.5.3 GEOGRAPHIC PRESENCE
28.5.4 PRODUCT PORTFOLIO
28.5.5 RECENT DEVELOPMENTS
28.6 DRÄGERWERK AG & CO. KGAA
28.6.1 COMPANY OVERVIEW
28.6.2 REVENUE ANALYSIS
28.6.3 GEOGRAPHIC PRESENCE
28.6.4 PRODUCT PORTFOLIO
28.6.5 RECENT DEVELOPMENTS
28.7 SCHILLER AMERICAS, INC.
28.7.1 COMPANY OVERVIEW
28.7.2 REVENUE ANALYSIS
28.7.3 GEOGRAPHIC PRESENCE
28.7.4 PRODUCT PORTFOLIO
28.7.5 RECENT DEVELOPMENTS
28.8 BUNNELL
28.8.1 COMPANY OVERVIEW
28.8.2 REVENUE ANALYSIS
28.8.3 GEOGRAPHIC PRESENCE
28.8.4 PRODUCT PORTFOLIO
28.8.5 RECENT DEVELOPMENTS
28.9 PENLON LIMITED
28.9.1 COMPANY OVERVIEW
28.9.2 REVENUE ANALYSIS
28.9.3 GEOGRAPHIC PRESENCE
28.9.4 PRODUCT PORTFOLIO
28.9.5 RECENT DEVELOPMENTS
28.1 RESMED
28.10.1 COMPANY OVERVIEW
28.10.2 REVENUE ANALYSIS
28.10.3 GEOGRAPHIC PRESENCE
28.10.4 PRODUCT PORTFOLIO
28.10.5 RECENT DEVELOPMENTS
28.11 VYAIRE
28.11.1 COMPANY OVERVIEW
28.11.2 REVENUE ANALYSIS
28.11.3 GEOGRAPHIC PRESENCE
28.11.4 PRODUCT PORTFOLIO
28.11.5 RECENT DEVELOPMENTS
28.12 ZOLL MEDICAL CORPORATION (SUBSIDIARY OF ASAHI KASEI)
28.12.1 COMPANY OVERVIEW
28.12.2 REVENUE ANALYSIS
28.12.3 GEOGRAPHIC PRESENCE
28.12.4 PRODUCT PORTFOLIO
28.12.5 RECENT DEVELOPMENTS
28.13 EVENT MEDICAL
28.13.1 COMPANY OVERVIEW
28.13.2 REVENUE ANALYSIS
28.13.3 GEOGRAPHIC PRESENCE
28.13.4 PRODUCT PORTFOLIO
28.13.5 RECENT DEVELOPMENTS
28.14 ALLIED MEDICAL LLC (A FLEXICARE COMPANY)
28.14.1 COMPANY OVERVIEW
28.14.2 REVENUE ANALYSIS
28.14.3 GEOGRAPHIC PRESENCE
28.14.4 PRODUCT PORTFOLIO
28.14.5 RECENT DEVELOPMENTS
28.15 GE HEALTHCARE
28.15.1 COMPANY OVERVIEW
28.15.2 REVENUE ANALYSIS
28.15.3 GEOGRAPHIC PRESENCE
28.15.4 PRODUCT PORTFOLIO
28.15.5 RECENT DEVELOPMENTS
28.16 NIHON KODEN CORPORATION
28.16.1 COMPANY OVERVIEW
28.16.2 REVENUE ANALYSIS
28.16.3 GEOGRAPHIC PRESENCE
28.16.4 PRODUCT PORTFOLIO
28.16.5 RECENT DEVELOPMENTS
28.17 AIRON CORPORATION
28.17.1 COMPANY OVERVIEW
28.17.2 REVENUE ANALYSIS
28.17.3 GEOGRAPHIC PRESENCE
28.17.4 PRODUCT PORTFOLIO
28.17.5 RECENT DEVELOPMENTS
28.18 BIO-MED DEVICES
28.18.1 COMPANY OVERVIEW
28.18.2 REVENUE ANALYSIS
28.18.3 GEOGRAPHIC PRESENCE
28.18.4 PRODUCT PORTFOLIO
28.18.5 RECENT DEVELOPMENTS
28.19 HILL-ROM SERVICES, INC. (BAXTER)
28.19.1 COMPANY OVERVIEW
28.19.2 REVENUE ANALYSIS
28.19.3 GEOGRAPHIC PRESENCE
28.19.4 PRODUCT PORTFOLIO
28.19.5 RECENT DEVELOPMENTS
28.2 NARANG MEDICAL LIMITED
28.20.1 COMPANY OVERVIEW
28.20.2 REVENUE ANALYSIS
28.20.3 GEOGRAPHIC PRESENCE
28.20.4 PRODUCT PORTFOLIO
28.20.5 RECENT DEVELOPMENTS
28.21 SKANRAY TECHNOLOGIES LTD
28.21.1 COMPANY OVERVIEW
28.21.2 REVENUE ANALYSIS
28.21.3 GEOGRAPHIC PRESENCE
28.21.4 PRODUCT PORTFOLIO
28.21.5 RECENT DEVELOPMENTS
28.22 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
28.22.1 COMPANY OVERVIEW
28.22.2 REVENUE ANALYSIS
28.22.3 GEOGRAPHIC PRESENCE
28.22.4 PRODUCT PORTFOLIO
28.22.5 RECENT DEVELOPMENTS
28.23 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
28.23.1 COMPANY OVERVIEW
28.23.2 REVENUE ANALYSIS
28.23.3 GEOGRAPHIC PRESENCE
28.23.4 PRODUCT PORTFOLIO
28.23.5 RECENT DEVELOPMENTS
28.24 PRUNUS MEDICAL
28.24.1 COMPANY OVERVIEW
28.24.2 REVENUE ANALYSIS
28.24.3 GEOGRAPHIC PRESENCE
28.24.4 PRODUCT PORTFOLIO
28.24.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
29 RELATED REPORTS
30 CONCLUSION
31 QUESTIONNAIRE
32 ABOUT DATA BRIDGE MARKET RESEARCH
